Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-404.33%EBITDA Margin
VS
Market
Sector
Industry
History
$ 5.59Close
$ 1.93 - $ 6.17 52-Week Range
Ticker Information
Ticker
ABCLCompany Name
ABCELLERA BIOLOGICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQABCELLERA BIOLOGICS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ABCL - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -132.93M | -404.33% | $ 32.88M |
| 3/31/2025 | $ -113.8M | -492.3% | $ 23.11M |
| 12/31/2024 | $ -103.4M | -358.61% | $ 28.83M |
| 9/30/2024 | $ -109.96M | -333.59% | $ 32.96M |
| 6/30/2024 | $ -117.49M | -355.44% | $ 33.05M |
| 3/31/2024 | $ -138.09M | -385.85% | $ 35.79M |
| 12/31/2023 | $ -143.13M | -376.42% | $ 38.02M |
| 9/30/2023 | $ -115.65M | -229.5% | $ 50.39M |
| 6/30/2023 | $ -30.47M | -20.99% | $ 145.18M |
| 3/31/2023 | $ -565K | -0.31% | $ 181.04M |
Key Performance Insights, Last 5 Years
- ABCELLERA BIOLOGICS INC's latest trailing twelve months (TTM) EBITDA % stands at -1.33%.
- Over the past 5 years, ABCELLERA BIOLOGICS INC's average EBITDA % has been -139.29%.
- The median EBITDA % for ABCELLERA BIOLOGICS INC during this period was -11.16%
- ABCELLERA BIOLOGICS INC reached its highest EBITDA % over the past 5 years at 72.75%.
- The lowest EBITDA % recorded by ABCELLERA BIOLOGICS INC in the same timeframe -492.3%
ABCELLERA BIOLOGICS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for ABCELLERA BIOLOGICS INC is calculated as follows: EBITDA [ $ -154.61K ] / Revenues [ $ 11.61M ]
(=) EBITDA % [ -1.33% ] ABCL - EBITDA Margin, Last 5 years
-492.3%
Minimum
Mar 31, 2025
72.75%
Maximum
Dec 31, 2020
-139.29%
Average
-11.16%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -75.07% |
| max | 97.73% |
| average | 16.12% |
| median | 14.72% |
| std | 26.88% |